Metformin Sandoz

Metformin Hydrochloride, the active ingredient in Metformin Sandoz, is a Biguanide presented as a tablet (strength unknown) for oral use. It reduces hepatic glucose production and improves peripheral insulin sensitivity, helping to control blood sugar levels in adults with type 2 diabetes mellitus.

GNH USA supplies Metformin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is manufactured under strict quality controls.

Metformin Sandoz, a biguanide antidiabetic, is used to manage hyperglycemia in type 2 diabetes and related conditions. - Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial glucose levels. - Impaired glucose tolerance: helps delay progression to overt diabetes when combined with lifestyle measures. - Polycystic ovary syndrome: may improve insulin resistance and menstrual regularity in affected women.

Metformin Sandoz may cause a range of adverse reactions, most of which are related to the gastrointestinal system.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Diarrhea: loose stools, often transient. - Abdominal discomfort: cramping or pain in the stomach area. - Metallic taste: persistent metallic sensation in the mouth. - Loss of appetite: reduced desire to eat.

Serious or Rare Side Effects: - Lactic acidosis: buildup of lactic acid, a medical emergency. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: abnormal liver enzyme elevations. - Hypoglycemia: low blood sugar, usually when combined with other antidiabetic agents. - Pancreatitis: inflammation of the pancreas presenting with abdominal pain.

When prescribing Metformin Sandoz, several safety considerations should be observed. - Renal function assessment: evaluate eGFR before initiating and periodically thereafter. - Lactic acidosis risk: avoid in patients with severe renal impairment, hepatic disease, or excessive alcohol intake. - Alcohol consumption: limit intake to reduce risk of metabolic acidosis. - Surgery or radiographic contrast: temporarily discontinue metformin before and after the procedure. - Pregnancy and lactation: use only if potential benefits justify potential risks to the fetus or infant. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and heat.

Metformin Sandoz can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate renal failure; hold metformin before and after imaging. - Cimetidine: increases metformin plasma concentrations, raising risk of toxicity. - Alcohol: synergistic effect increasing risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors or ARBs: require monitoring of renal function and electrolytes. - Thyroid hormones: may influence glucose metabolism, necessitating glucose monitoring.